“We obviously we're looking to close the transaction in the second half of the year. And one we do, we'll assess the environment at the time.”

In context

“st about a point. So we don't expect these to be recurring as I mentioned. And so, you could essentially normalize for those on a go-forward basis. Elyse Greenspan: Thanks. And then my second question, you guys saw buyback pick up in July. So is that July level kind of a good run rate from here? As we think about the holding transaction closing and then I also believe, your subsidiary dividends are typically, greater in the back half of the year? Michel Khalaf: Hi. Good morning, Elyse. Michelle here. So I would say that there was a bit of catch-up in July given the fact that we were in blackout for, part of the second quarter due to the re-insurance transaction. So, if you look at probably the sort of run rate up to July here to date, I think that gives you a good sense of sort of pacing. We obviously we're looking to close the transaction in the second half of the year. And one we do, we'll assess the environment at the time. I think we've built a good track record here in terms of, after major divestitures in terms of how we we're deliberate and expeditious and returning access capital and, expect the same here. Elyse Greenspan: Thanks, Michelle. Operator: And next we go to Erik Bass with Autonomous Research. Please go ahead. Erik Bass: Hi, thank you. Can you provide some more color on your non-medical health underwriting results this quarter, in particular, the experience in dental and disability and how you're thinking about those going forward? Ramy Tadros: Sure, Erik. It's Ramy here. So, I'll start with disability. So, all results this quarter were favorable year-over-year. We're seeing favorable incidents and very strong recovery levels and I'm very pleased with the performance of that line this quarter.”